Recipharm AB has acquired Abbott’s (formerly Solvay Pharmaceuticals) manufacturing site in Parets, close to Barcelona, Spain. Parets produces solid dose, sterile ointments, oral liquids, aerosols and topical products. The newly acquired business will be called Recipharm Parets SL. Financial details were not disclosed. The acquisition adds to Recipharm’s capabilities and provides entry into the Spanish market. Recipharm will continue to produce all Abbott products currently manufactured at the...